Euclidean Capital

Euclidean Capital

Euclidean Capital

Latest investments Show all
$71,500,000
Venture capital (Series B)
A2 Biotherapeutics
$50,000,000
Venture capital (Series B)
Dascena
Team Size
1–10
Employees
Past year's investments
  • 4 rounds in the past year
  • $418.5M deployed in total
  • $104.6M avg per round
Latest rounds
  • A2 Biotherapeutics: Venture capital (Series B) ($71.5M)
  • Dascena: Venture capital (Series B) ($50M)
  • ASAPP: Venture capital (Series B) ($185M)